Tryptophan and inhibitors of tryptophan 2,3-dioxygenase as antidepressants: Reply

Journal of Psychopharmacology

Volumn 28, Issue 2, 2014, Pages 1-3

  Badawy, Abdulla A B ^a  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; ENZYME INHIBITOR; INDOLEAMINE 2,3 DIOXYGENASE; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; TRYPTOPHAN 2,3 DIOXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

BLOOD LEVEL; CEREBROSPINAL FLUID ANALYSIS; DEGRADATION KINETICS; DRUG DOSE REGIMEN; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; LETTER; MAJOR DEPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN METABOLISM; SLOW DRUG RELEASE; SPECIES DIFFERENCE; ANIMAL; BIOSYNTHESIS; BRAIN; DRUG EFFECT; METABOLISM; NOTE;

ANIMALS; BRAIN; DEPRESSIVE DISORDER, MAJOR; HUMANS; SEROTONIN; TRYPTOPHAN;

EID: 84892918354     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113512044     Document Type: Letter

References (32)

1. Badawy AA-B. Perspective: Tryptophan: The key to boosting brain serotonin synthesis in depressive illness. J Psychopharmacol. 2013 ; 27: 878-893
2. Badawy AA-B, Evans M. Guinea pig liver tryptophan pyrrolase - absence of detectable apoenzyme activity and of hormonal induction by cortisol and possible regulation by tryptophan. Biochem J. 1974 ; 138: 445-451
3. Badawy AA-B, Evans M. The regulation of rat liver tryptophan pyrrolase by its cofactor haem - experiments with haematin and 5-aminolaevulinate and comparison with the substrate and hormonal mechanisms. Biochem J. 1975 ; 150: 511-520
4. Badawy AA-B, Evans M. Animal liver tryptophan pyrrolases - absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicity. Biochem J. 1976a ; 158: 79-88
5. Badawy AA-B, Evans M. The role of free serum tryptophan in the biphasic effect of acute ethanol administration on the concentrations of rat brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid. Biochem J. 1976b ; 160: 315-324
6. Badawy AA-B, Dougherty DM, Richard DM. Specificity of the acute tryptophan and tyrosine plus phenylalanine depletion and loading tests Part II: Normalisation of the tryptophan and tyrosine plus phenylalanine to competing amino acid ratios in a new control formulation. Int J Tryptophan Res. 2010 ; 3: 35-47
7. Banki CM, Molnar G. Cerebrospinal fluid 5-hydroxindoleacetic acid as an index of central serotonergic processes. Psychiatry Res. 1981 ; 5: 23-32 (Pubitemid 11059519)
8. Barton DA, Esler MD, Dawood T, et al. Elevated brain serotonin turnover in patients with depression: Effect of genotype and therapy. Arch Gen Psychiat. 2008 ; 65: 38-46
9. Baughman KL, Franz JM. Control of tryptophan oxygenase and formamidase activity in the gerbil. Int J Biochem. 1971 ; 2: 201-211
10. Bender DA. Biochemistry of tryptophan in health and disease. Molec Aspects Med. 1982 ; 6: 101-197 (Pubitemid 13178235)
11. Bonkale WL, Murdock S, Janosky JE, et al. Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphé of depressed suicide victims. J Neurochem. 2004 ; 88: 958-964 (Pubitemid 38199317)
12. Cook JS, Pogson CI, Smith SA. Indoleamine 2,3-dioxygenase. A new, rapid, sensitive radiometric assay and its application to the study of the enzyme in rat tissues. Biochem J. 1980 ; 189: 461-466 (Pubitemid 11232979)
13. Costa C, De Antoni A, Bacchichetti F, et al. Metabolites and enzyme activities involved in tryptophan metabolism in two different strains of mouse. Ital J Biochem. 1984 ; 33: 319-324 (Pubitemid 15188507)
14. Gjerris A. Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression?. Acta Psychiat Scand Suppl. 1988 ; 345: 21-24
15. Green AR, Sourkes TL, Young SN. Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils. Br J Pharmacol. 1975 ; 53: 287-292
16. Hou C, Jia F, Liu Y, et al. CSF serotonin, 5-hydroxyindoleacetic acid and neuropeptide Y levels in severe major depressive disorder. Brain Res. 2006 ; 1095: 154-158 (Pubitemid 43866025)
17. Huether G, Hajak G, Reimer A, et al. The metabolic fate of infused L-tryptophan in men: Possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolites. Psychopharmacol. 1992 ; 109: 422-432
18. Kennedy JS, Gwirtsman HE, Schmidt DE, et al. Serial cerebrospinal fluid tryptophan and 5-hydroxy indoleacetic acid concentrations in healthy human subjects. Life Sc. 2002 ; 23: 1703-1715 (Pubitemid 34879074)
19. Knox WE. The regulation of tryptophan pyrrolase activity by tryptophan. Adv Enzyme Regul. 1966 ; 4: 287-297
20. Larsson M, Forsman A, Hallgren J. HPLC assays of 5-HIAA and tryptophan in cerebrospinal fluid and 5-HT and tryptophan in blood: A methodological study with clinical applications. Methods Find Exp Clin Pharmacol. 1988 ; 10: 453-460
21. Meltzer HY, Lowy MT Psychopharmacology: The Third Generation of Progress. Meltzer HY, ed. New York: Raven Press, pp ; 1987: 513-526.
22. Meyer JH, Ginovart N, Boovariwala A, et al. Elevated monoamine oxidase a levels in the brain: An explanation of the monoamine imbalance of major depression. Arch Gen Psychiat. 2006 ; 63: 1209-1216 (Pubitemid 44708079)
23. Monroe CB. Induction of tryptophan pyrrolase and tyrosine aminotransferase in mice. Am J Physiol. 1968 ; 214: 1410-1414
24. Moreno FA, Parkinson D, Palmer C, et al. CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls. Eur Neuropsychopharmacol. 2010 ; 20: 18-24
25. Nordin C. Relationship between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients. Acta Psychiat Scand. 1988 ; 78: 720-729 (Pubitemid 19027342)
26. Opmeer EM, Kortekaas S, Aleman A, et al. Depression and the role of genes involved in dopamine metabolism and signalling. Progr Neurobiol. 2010 ; 92: 112-133
27. Sedlmayr P, Blaschitz A, Wintersteiger R, et al. Localisation of indoleamine 2,3-dioxygenase in human female reproductive organs and placenta. Mol Human Reprod. 2002 ; 8: 385-391 (Pubitemid 34303247)
28. Yamazaki F, Kuroiwa T, Takikawa O, et al. Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J. 1985 ; 230: 635-638 (Pubitemid 16236320)
29. Young SN. Tryptophan and inhibitors of tryptophan 2,3-dioxygenase as antidepressants. J Psychopharmacol. 2013 in press ;:
30. Young SN, Gauthier S. Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiat. 1981 ; 44: 323-327
31. Young SN, Lal S, Martin JB, et al. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow. Psychiat Neurol Neurochir. 1973 ; 76: 439-444
32. Yuwiler A, Brammer GL, Morley JE, et al. Short-term and repetitive administration of oral tryptophan in normal men. effects on blood tryptophan, serotonin, and kynurenine concentrations. Arch Gen Psychiat. 1981 ; 38: 619-626 (Pubitemid 11064818)